Vaxinano
PrivateLast Round
Series A
Oct 29, 2024
Total Funding Raised
$7.09M
Company Overview
Vaxinano is a biotechnology company that develops prophylactic and therapeutic nasal vaccines intended to treat infectious diseases for human and animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vaxinano Comps
Public and private peers based on sector, stage, and business model.
Vaxinano Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 29, 2024 | ||||
| Grant | Jun 1, 2020 | ||||
| Seed | Jun 22, 2017 |
Key People
Founding team and executive leadership
Vaxinano Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agence Nationale de la Recherche | Grant |
| Bpifrance | Series A |
| WiSeed | Series A |
| TCD Capital | Series A |
Vaxinano Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vaxinano's valuation, stock price, and market status.
